Pfizer Inc. (NYSE:PFE) has a beta value of 0.65 and has seen 23.48 million shares traded in the last trading session. The company, currently valued at $164.79B, closed the last trade at $29.08 per share which meant it lost -$0.08 on the day or -0.27% during that session. The PFE stock price is -16.64% off its 52-week high price of $33.92 and 13.34% above the 52-week low of $25.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 32.25 million shares traded. The 3-month trading volume is 31.90 million shares.
The consensus among analysts is that Pfizer Inc. (PFE) is Buy stock at the moment, with a recommendation rating of 2.20. 1 analysts rate the stock as a Sell, while 1 rate it as Overweight. 7 out of 16 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.59.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pfizer Inc. (NYSE:PFE) trade information
Sporting -0.27% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PFE stock price touched $29.08 or saw a rise of 4.44%. Year-to-date, Pfizer Inc. shares have moved 1.01%, while the 5-day performance has seen it change -0.41%. Over the past 30 days, the shares of Pfizer Inc. (NYSE:PFE) have changed -0.65%. Short interest in the company has seen 67.62 million shares shorted with days to cover at 2.23.
Wall Street analysts have a consensus price target for the stock at $46, which means that the shares’ value could jump 36.78% from current levels. The projected low price target is $20.0 while the price target rests at a high of $70.0. In that case, then, we find that the current price level is -140.72% off the targeted high while a plunge would see the stock lose 31.22% from current levels.
Pfizer Inc. (PFE) estimates and forecasts
Figures show that Pfizer Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained 12.23% over the past 6 months, with this year growth rate of 44.57%, compared to 6.30% for the industry. Revenue growth from the last financial year stood is estimated to be 4.40%.
14 analysts offering their estimates for the company have set an average revenue estimate of 14.76B for the current quarter. 12 have an estimated revenue figure of 18.09B for the next ending quarter. Year-ago sales stood 13.23B and 14.25B respectively for this quarter and the next, and analysts expect sales will grow by 11.60% for the current quarter and 4.40% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -27.43% over the past 5 years. Earnings growth for 2024 is a modest 44.59% while over the next 5 years, the company’s earnings are expected to increase by 10.00%.
PFE Dividends
Pfizer Inc. is expected to release its next earnings report on 2024-Oct-29 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 1.67 at a share yield of 5.74%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 4.2%.
Pfizer Inc. (NYSE:PFE)’s Major holders
Insiders own 0.05% of the company shares, while shares held by institutions stand at 67.53% with a share float percentage of 67.56%. Investors are also buoyed by the number of investors in a company, with Pfizer Inc. having a total of 3618.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 511.4 million shares worth more than $14.31 billion. As of 2024-06-30, VANGUARD GROUP INC held 9.0402% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 424.38 million shares as of 2024-06-30. The firm’s total holdings are worth over $11.87 billion and represent 7.5018% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund . As of Jun 30, 2024 , the former fund manager holds about 3.16% shares in the company for having 179.12 shares of worth $5.21 billion while later fund manager owns 145.44 shares of worth $4.23 billion as of Jun 30, 2024 , which makes it owner of about 2.57% of company’s outstanding stock.
